Works matching IS 15228517 AND DT 2016 AND VI 18 AND IP 2
Results: 21
Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 236, doi. 10.1093/neuonc/nov154
- By:
- Publication type:
- Article
The intersection of cancer, cancer stem cells, and the immune system: therapeutic opportunities.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 153, doi. 10.1093/neuonc/nov157
- By:
- Publication type:
- Article
Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 261, doi. 10.1093/neuonc/nov167
- By:
- Publication type:
- Article
Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 291, doi. 10.1093/neuonc/nou357
- By:
- Publication type:
- Article
Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 216, doi. 10.1093/neuonc/nov114
- By:
- Publication type:
- Article
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 244, doi. 10.1093/neuonc/nov162
- By:
- Publication type:
- Article
Society news.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 301, doi. 10.1093/neuonc/nov323
- Publication type:
- Article
PD-L1 expression and prognostic impact in glioblastoma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 195, doi. 10.1093/neuonc/nov172
- By:
- Publication type:
- Article
Vascular biomarkers derived from dynamic contrast-enhanced MRI predict response of vestibular schwannoma to antiangiogenic therapy in type 2 neurofibromatosis.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 275, doi. 10.1093/neuonc/nov168
- By:
- Publication type:
- Article
Predicting glioblastoma response to bevacizumab through marker profiling?
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 149, doi. 10.1093/neuonc/nov320
- By:
- Publication type:
- Article
Highlights from the Literature.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 151, doi. 10.1093/neuonc/nov324
- Publication type:
- Article
Serum exosomes and cytokines promote a T-helper cell type 2 environment in the peripheral blood of glioblastoma patients.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 206, doi. 10.1093/neuonc/nov107
- By:
- Publication type:
- Article
Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 227, doi. 10.1093/neuonc/nov123
- By:
- Publication type:
- Article
Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 298, doi. 10.1093/neuonc/nov314
- By:
- Publication type:
- Article
Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 184, doi. 10.1093/neuonc/nov105
- By:
- Publication type:
- Article
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 283, doi. 10.1093/neuonc/nov307
- By:
- Publication type:
- Article
The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 252, doi. 10.1093/neuonc/nov166
- By:
- Publication type:
- Article
Radiation de-intensification for patients with glioblastoma and poor prognostic features--how much do we really know?
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 147, doi. 10.1093/neuonc/nov311
- By:
- Publication type:
- Article
A prognostic cytogenetic scoring system to guide the adjuvant management of patients with atypical meningioma.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 269, doi. 10.1093/neuonc/nov177
- By:
- Publication type:
- Article
Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 160, doi. 10.1093/neuonc/nov125
- By:
- Publication type:
- Article
Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 2, p. 173, doi. 10.1093/neuonc/nov288
- By:
- Publication type:
- Article